Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of V.F. Corporation securities between October 30, 2023, and May 20, 2025, alleging that the company disseminated materially false and misleading statements regarding its turnaround plans [1][5]. Group 1: Lawsuit Details - The lawsuit claims that V.F. Corporation concealed significant reset actions necessary for the Vans brand to return to growth, which negatively impacted revenue growth [5]. - Investors who purchased V.F. Corporation securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by November 12, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline for a class action lawsuit related to the company's July 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 30, 2025 [3]. - The lawsuit claims that the registration statement issued during the IPO was false and/or misleading, failing to disclose significant issues affecting Lineage's business [5]. Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage was experiencing a decline in customer demand due to increased cold-storage supply and customers destocking excess inventory from the COVID-19 pandemic [5]. - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5]. - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Group 1 - A class action lawsuit has been filed on behalf of shareholders who purchased securities of Quanex Building Products Corporation between December 12, 2024, and September 5, 2025 [1] - Quanex Building Products Corporation is described as an international supplier of engineered home components and access solutions to the construction industry, including products such as windows, doors, cabinetry, and vinyl products [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities between May 7, 2025, and August 5, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought LifeMD securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 27, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding LifeMD's competitive position and failed to account for rising customer acquisition costs in their 2025 guidance [5]. - It is claimed that the defendants' statements about LifeMD's business operations and prospects were materially false and misleading, leading to investor damages when the true information became public [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Sable Offshore Corp. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - The Class Period for the securities class action is defined as between May 19, 2025, and June 3, 2025, inclusive, and includes those who participated in Sable's secondary public offering on May 21, 2025 [1]. - Investors who purchased Sable securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must move the Court by September 26, 2025 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4]. Group 3: Allegations Against Sable Offshore Corp. - The lawsuit alleges that Sable made materially false and misleading statements regarding its oil production activities off the coast of California, which were not true [5]. - As a result of these misleading statements, investors suffered damages when the true information became public [5].

Core Viewpoint - A class action lawsuit has been filed against Charter Communications, Inc. for misleading statements regarding its business operations and the impact of the FCC's Affordable Connectivity Program ending, which allegedly led to investor damages during the specified Class Period [1][5]. Group 1: Lawsuit Details - The class action lawsuit covers purchasers of Charter Communications securities and options between July 26, 2024, and July 24, 2025 [1]. - The lawsuit claims that Charter Communications made false or misleading statements about its ability to manage the impact of the FCC's Affordable Connectivity Program ending, which affected internet customer declines and revenue [5]. - The lawsuit alleges that Charter failed to execute operations effectively to compensate for the adverse effects of the ACP ending, leading to greater risks on business plans and earnings growth than reported [5]. Group 2: Investor Information - Investors who purchased securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by October 13, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4]. - The firm emphasizes the importance of selecting qualified counsel with a proven success record in leadership roles [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of KinderCare Learning Companies, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's October 2024 IPO [1][3]. Group 1: Class Action Details - Investors who purchased KinderCare common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 14, 2025 [3]. - The lawsuit alleges that the registration statement was false and/or misleading, failing to disclose incidents of child abuse and neglect at KinderCare facilities, and that the company did not meet minimum care standards [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been recognized as a leader in securities class action settlements [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Jasper Therapeutics, Inc. during the specified Class Period from November 30, 2023, to July 3, 2025, due to alleged misleading statements and failures to disclose critical information [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Jasper Therapeutics lacked necessary controls and procedures for third-party manufacturers, which could lead to non-compliance with cGMP regulations [5]. - It is alleged that this failure increased the risk of confounding results in ongoing studies, negatively impacting the regulatory and commercial prospects of Jasper's products, particularly briquilimab [5]. - The lawsuit asserts that Jasper's business and financial prospects were overstated, and public statements made by the defendants were materially false and misleading [5]. Group 2: Class Action Participation - Investors who purchased Jasper Therapeutics securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent the interests of other class members in the litigation [1][3]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Replimune Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Replimune securities class action is from November 22, 2024, to July 21, 2025 [1]. - Investors who purchased Replimune securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by September 22, 2025, to represent other class members in the litigation [3]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding the IGNYTE trial's prospects, which the FDA deemed inadequate [5]. - It is claimed that the defendants knew or should have known about material issues affecting the trial, leading to misleading statements about Replimune's business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for misleading statements regarding its financial performance and project costs during the Class Period from February 18, 2025, to July 31, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Fluor made false and misleading statements about the costs associated with several major projects, including the Gordie Howe International Bridge and various Texas highways, due to subcontractor errors, price increases, and scheduling delays [5]. - It is alleged that these issues, along with reduced customer capital spending and economic uncertainty, negatively impacted Fluor's business and financial results [5]. - The lawsuit asserts that Fluor's financial guidance for 2025 was unreliable and that the company's risk mitigation strategies were overstated [5]. Group 2: Investor Information - Investors who purchased Fluor securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by November 14, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].